KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Current Deferred Revenue (2018 - 2025)

BioNTech SE's Current Deferred Revenue history spans 8 years, with the latest figure at $878.7 million for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue rose 178.85% to $878.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $878.7 million, a 178.85% increase, with the full-year FY2025 number at $852.9 million, up 170.65% from a year prior.
  • Current Deferred Revenue hit $878.7 million in Q4 2025 for BioNTech SE, down from $930.7 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for BNTX hit a ceiling of $1.1 billion in Q2 2025 and a floor of $48.9 million in Q1 2023.
  • Historically, Current Deferred Revenue has averaged $454.6 million across 5 years, with a median of $384.0 million in 2021.
  • Biggest five-year swings in Current Deferred Revenue: tumbled 77.29% in 2023 and later skyrocketed 741.67% in 2024.
  • Tracing BNTX's Current Deferred Revenue over 5 years: stood at $212.9 million in 2021, then plummeted by 63.05% to $78.7 million in 2022, then surged by 445.08% to $428.8 million in 2023, then fell by 26.5% to $315.1 million in 2024, then soared by 178.85% to $878.7 million in 2025.
  • Business Quant data shows Current Deferred Revenue for BNTX at $878.7 million in Q4 2025, $930.7 million in Q3 2025, and $1.1 billion in Q2 2025.